Montelukast Prescribing at FITZALAN MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,869
Total Quantity
49.1K
NHS Cost
£2.5K
vs National Avg
+173%
FITZALAN MEDICAL GROUP prescribed 1,869 items of Montelukast over the last 12 months at a cost of £2,537 to the NHS. This is 173% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
172
Jul 2026
145
Jul 2026
158
Jul 2026
134
Jul 2026
146
Jul 2026
175
Jul 2026
158
Jul 2026
162
Jul 2026
176
Jul 2026
129
Jul 2026
162
Jul 2026
152
Prescribing Details
| Total Items | 1,869 |
|---|---|
| Total Quantity | 49,113 |
| Total NHS Cost | £2,537 |
| Presentations | 4 different forms |
| vs National Average | +173% |
Montelukast Prescribing Comparison
| This practice | 1,869 items |
|---|---|
| National average per practice | 685 items |
| Difference | +173% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.